You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

CLINICAL TRIALS PROFILE FOR DAYTRANA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Daytrana

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00434213 ↗ Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA Completed Noven Therapeutics Phase 4 2007-01-01 This is a study designed to characterize the dermal response of DAYTRANA. Subjects will visit the study site over a period of approximately 14 weeks.
NCT00499863 ↗ Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD Completed Noven Therapeutics Phase 3 2007-07-01 To assess the efficacy and safety of efficacy of MTS compared to placebo
NCT00501293 ↗ Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD Completed Noven Therapeutics Phase 3 2007-08-01 To evaluate the long-term, safety of Methylphenidate Transdermal System (MTS) in aged 13-17 years diagnosed withADHD
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Daytrana

Condition Name

Condition Name for Daytrana
Intervention Trials
Attention Deficit Hyperactivity Disorder 7
ADHD 3
Advanced Malignant Neoplasm 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Daytrana
Intervention Trials
Attention Deficit Disorder with Hyperactivity 11
Hyperkinesis 8
Fatigue 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Daytrana

Trials by Country

Trials by Country for Daytrana
Location Trials
United States 70
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Daytrana
Location Trials
Texas 5
Ohio 4
Virginia 4
Kentucky 3
Arizona 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Daytrana

Clinical Trial Phase

Clinical Trial Phase for Daytrana
Clinical Trial Phase Trials
Phase 4 5
Phase 3 5
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Daytrana
Clinical Trial Phase Trials
Completed 10
Recruiting 2
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Daytrana

Sponsor Name

Sponsor Name for Daytrana
Sponsor Trials
Noven Therapeutics 3
Shire 2
National Cancer Institute (NCI) 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Daytrana
Sponsor Trials
Other 14
Industry 5
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.